fig1

Macrophage STING activation induces cardiomyocyte hypertrophy

Figure 1. STING was activated in the heart tissues of HFpEF mice. (A and B) PW mode analysis of early to late diastolic flow velocity ratio (E/A); (C-G) M-mode analysis of left ventricular ejection fraction (EF) and fractional shortening (FS); (H) Representative image and analysis of WGA staining; (I) Representative image and analysis of Sirius Red staining; (J and K) Protein and phosphorylated levels of STING (Ser365) and IRF3 (Ser396) in cardiac tissues; (L) mRNA levels of TNF-α, IL-6, IL-1β and IFN-β in cardiac tissues. Mean ± SEM; n = 6 in each group, *P < 0.05, ***P < 0.001, ns, no significance. Student’s t-test for 1B-I, 1K-L. STING: Stimulator of interferon genes; HFpEF: heart failure with preserved ejection fraction; WGA: wheat germ agglutinin; mRNA: messenger RNA; SEM: standard error of the mean; TNF-α: tumour necrosis factor; IL-1β: interleukin-1β; IFN-β: interferon-β; IL-6: interleukin-6; PW: pulsed wave; IRF3: interferon regulatory factor 3; L-NAME: Nω-nitro-L-arginine methyl ester; HFD: high-fat diet.

The Journal of Cardiovascular Aging

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/